Corient Private Wealth’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$743K Buy
62,422
+17,298
+38% +$177K ﹤0.01% 1812
2025
Q4
$455K Buy
45,124
+24,356
+117% +$233K ﹤0.01% 2372
2025
Q3
$186K Buy
20,768
+176
+0.9% +$1.63K ﹤0.01% 2361
2025
Q2
$194K Sell
20,592
-204
-1% -$1.8K ﹤0.01% 2247
2025
Q1
$225K Sell
20,796
-359
-2% -$3.61K ﹤0.01% 2005
2024
Q4
$201K Buy
21,155
+5,811
+38% +$58.8K ﹤0.01% 2115
2024
Q3
$172K Buy
15,344
+3,382
+28% +$35.9K ﹤0.01% 2249
2024
Q2
$120K Buy
+11,962
New +$122K ﹤0.01% 2190

Other funds holding AHCO

Corient Private Wealth's AHCO Position: Q1 2026 in Review

Corient Private Wealth increased its AdaptHealth (AHCO) stake by 38% in Q1 2026, buying an estimated $177K and bringing the position to 62,422 shares worth $743K. The position accounts for ﹤0.01% of the portfolio, ranked #1812.

Corient Private Wealth first reported a position in AHCO in Q2 2024 and has held it in 8 quarters since. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Corient Private Wealth held 62,422 shares of AdaptHealth worth $743K as of Q1 2026.
  • Corient Private Wealth bought 17,298 AdaptHealth shares in Q1 2026, an estimated $177K.
  • AdaptHealth made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1812 holding.
  • Corient Private Wealth first reported a position in AdaptHealth in Q2 2024 and has held it in 8 quarters since.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.